| Financial Year |
March 31 2023 |
| Monetary Funds |
343,872,740.94 |
| Held-for-trading Financial Assets |
50,681,972.22 |
| Notes Receivable |
-- |
| Accounts Receivable |
279,380,469.41 |
| Advances to Suppliers |
17,813,147.82 |
| Other Receivables |
23,066,721.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
198,984,835.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,393,305.68 |
| Total Current Assets |
918,193,192.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
8,236,732.78 |
| Fixed Assetes |
436,637,555.52 |
| Under-construction Projects |
133,389,363.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
73,520,244.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,391,457.94 |
| Deferred Income Tax Assets |
8,869,646.24 |
| Other Non-Current Assets |
31,951,721.82 |
| Sub-Total of Non-Current Assets |
703,413,390.47 |
| Total Assets |
1,621,606,583.26 |
| Short-Term Loans |
12,012,466.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
147,796,651.17 |
| Accounts Received In Advance |
207,865.74 |
| Employee Compensation Payable |
11,572,676.63 |
| Taxes Payable |
43,113,374.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,938,547.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,949,523.95 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
219,839,438.20 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,026.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
77,745,894.76 |
| Total Liabilities |
297,585,332.96 |
| Paid-In Capital(Or Share Stock) |
400,010,000.00 |
| Capital Surplus |
430,609,508.98 |
| Surplus Reserve |
52,042,174.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
441,400,710.38 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,324,021,250.30 |
| Owner's Equity（Stockholder's Equity） |
1,324,021,250.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,621,606,583.26 |
